Company Information
Industry 制造业
Company Introduction 自成立以来,公司主营业务一直专注于外用药的研发、生产和销售,公司产品主要为非处方药品,使用方便,易于储存,属于家庭常备药。 公司产品涵盖消化类、皮肤类和五官类等细分领域,包括开塞露、甘油灌肠剂、炉甘石洗剂、氧化锌软膏、碘甘油、呋麻滴鼻液、氧氟沙星滴耳液、硫软膏、解痉镇痛酊、冻疮膏、复方薄荷脑软膏、尿素维E乳膏、硼酸洗液、苯扎溴铵酊、白花油、硼酸软膏、水杨酸软膏等,可用于治疗便秘(含小儿便秘)、皮炎湿疹、口腔溃疡、牙龈肿痛、牙周炎、鼻炎鼻塞、中耳炎、痤疮褥疮、跌打损伤、冻疮、晒伤烫伤、头癣、角质增生等常见疾病,也可以满足皮肤保养、伤口及环境消毒、创面收敛、感冒症状缓解、提神醒脑等日用护理需求。
Main Business 外用药的研发、生产和销售
Legal Representative 方之光
Top Executives
董事长:方之光
董事:张长伟,冯军,罗晓旭,方之光,鲁爱萍,方家辰
独立董事:杨力,余玮,卓福民
Top 5 Shareholder
Shareholder name Nature Holding Date
香港运佳限售股58.80%23/08/2024
嘉兴必余限售股3.60%23/08/2024
嘉兴有伽限售股3.60%23/08/2024
李卫红限售股1.50%23/08/2024
阮鸿献限售股1.50%23/08/2024
Company Secretary 罗晓旭
Solicitors 北京市君合律师事务所
Auditors 普华永道中天会计师事务所(特殊普通合伙)
Tel No 021-58207999
Fax No 021-58202666
Website www.xf-pharma.com
Email info@xf-pharma.com
Company Address
Register: 上海市奉贤区洪朱路777号
Office: 上海市奉贤区洪朱路777号
Listing Date 26/08/2024
Shares Capital
Shares Capital: 160,000,000
Total A Share: 160,000,000
Listed A Share: 39,197,752
Non-tradable A Share: 120,802,248
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.700
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 4.830
Market Capitalization(RMB) 0.853B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.